Literature DB >> 32299853

Experimental dyspnoea interferes with locomotion and cognition: a randomised trial.

David Lawi1, Elise Dupuis-Lozeron2,3, Gregory Berra1, Gilles Allali3,4,5, Thomas Similowski6,7, Dan Adler8,3.   

Abstract

BACKGROUND: Chronic respiratory diseases are associated with cognitive dysfunction, but whether dyspnoea by itself negatively impacts on cognition has not been demonstrated. Cortical networks engaged in subjects experiencing dyspnoea are also activated during other tasks that require cognitive input and this may provoke a negative impact through interference with each other.
METHODS: This randomised, crossover trial investigated whether experimentally-induced dyspnoea would negatively impact on locomotion and cognitive function among 40 healthy adults. Crossover conditions were unloaded breathing or loaded breathing using an inspiratory threshold load. To evaluate locomotion, participants were assessed by the Timed Up and Go (TUG) test. Cognitive function was assessed by categorical and phonemic verbal fluency tests, the Trail Making Tests (TMTs) A and B (executive function), the CODE test from the Wechsler Adult Intelligence Scale (WAIS)-IV (processing speed) and by direct and indirect digit span (working memory).
RESULTS: The mean time difference to perform the TUG test between unloaded and loaded breathing was -0.752 s (95% CI -1.012 to -0.492 s) (p<0.001). Executive function, processing speed and working memory performed better during unloaded breathing, particularly for subjects starting first with the loaded breathing condition.
CONCLUSION: Our data suggest that respiratory threshold loading to elicit dyspnoea had a major impact on locomotion and cognitive function in healthy adults.
Copyright ©ERS 2020.

Entities:  

Mesh:

Year:  2020        PMID: 32299853     DOI: 10.1183/13993003.00054-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  1 in total

1.  Dyspnea: The vanished warning symptom of COVID-19 pneumonia.

Authors:  Gilles Allali; Christophe Marti; Olivier Grosgurin; Capucine Morélot-Panzini; Thomas Similowski; Dan Adler
Journal:  J Med Virol       Date:  2020-06-29       Impact factor: 20.693

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.